Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Medical Officer
-
Issuer Symbol
-
TVTX on Nasdaq
Jula Inrig - trading volume in the past year for Travere Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
107,485 |
$3,452,418 |
$32.12 |
03 Feb 2026 |
Direct |
|
|
| Performance-based restricted stock units |
0 |
$0 |
$22.00 |
10 Feb 2025 |
Direct |
Common Stock |
|
| Employee stock option (right to buy) |
75,000 |
|
|
31 Jan 2026 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.